Ariana Pharma, a provider of non-statistical clinical data analysis technology to the pharmaceutical industry, has established a permanent US office in Cambridge, Massachusetts to expand global operations. In relation to the ...
Tags: Ariana Pharma, Ariana's Knowledge Extraction and Management, KEM
The 5th International Conference on Clinical Trials for Alzheimer's Disease (CTAD) will examine the phase 3 treatment trials of Alzheimer's Disease (AD) and also analyze the results to develop current and new drugs to tackle AD. The ...
Tags: CTAD, AD, Alzheimer's Disease
Cardiovascular Systems has completed enrolling 443 patients in the ORBIT II trial of its electric orbital atherectomy system(OAS),designed to treat severe calcified coronary arteries. The first premarket approval(PMA)trial,which is ...
Tags: cardiovascular system, OAS, severe calcified coronary arteries, ORBIT II
VentiRx Pharmaceuticals has formed a world-wide collaboration with Celgene Corporation to develop VTX-2337, a highly potent and selective TLR8 agonist for cancer treatment. As part of the agreement, Celgene will fund $35m as upfront ...
Teva Pharmaceutical has received US Food and Drug Administration(FDA)approval for Synribo injection to treat adult patients with chronic phase(CP)or accelerated phase(AP)chronic myeloid leukemia(CML)with resistance and/or intolerance to ...
Tags: Teva Synribo Injection, US FDA, Teva Pharmaceutical, chronic phase
Ten biopharmaceutical companies, Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson, Pfizer, Genentech and Sanofi have established a non-profit organization ...
Tags: biopharmaceutical companies, non-profit organization, new medicines
The British Standards Institution (BSI), a notified body under the Medical Device Directive, has awarded a CE mark for the expanded clinical indication for Harvest Technologies' SmartPReP 2 Bone Marrow Aspiration Concentration System (BMAC ...
Ariosa Diagnostics will present its non-invasive prenatal test's clinical data at the American Society of Human Genetics (ASHG) Annual Meeting being held in San Francisco, California, US, from 6 - 11 November 2012. The non-invasive test, ...
Tags: non-invasive prenatal test, ASHG, analysis, cell-free DNA
KevMed has entered into a collaboration agreement to distribute NanoVibronix's low-frequency ultrasound device in the US. The FDA-cleared PainShield is a wearable therapeutic device and features a disposable patch connected to a portable ...
Tags: KevMed, NanoVibronix, ultrasound device
Sapheon, a developer of technologies for the treatment of vascular diseases, has completed the first closing in its $18.5m Series B Preferred equity offering. The company said the proceeds from the Series B offering will be used to ...
American biotechnology firm XOMA has obtained orphan drug designation by the US Food & Drug Administration (FDA) for its IL-1 beta modulating antibody 'Gevokizumab', which treats non-infectious intermediate, posterior, pan-uveitis, or ...
Tags: American biotechnology, XOMA, orphan drug, FDA
Accenture has completed the acquisition of a provider of clinical and regulatory information management solutions and software, Octagon Research Solutions. The acquisition will enable Accenture to help its pharmaceutical clients by ...
Tags: Accenture, acquisition, clinical and regulatory information
Oregon Medical, a multi-specialty primary care group, has ordered for Carestream's Vue RIS+PACS+Reporting and Vue Cloud Archive. Carestream's Vue RIS+PACS+Reporting is designed for delivering mobile image and report viewing on web-based ...
Tags: web-based devices, advanced tools, mobile image devices
IDG News Service-The health care industry's increased use of electronic medical records(EMRs),wireless medical devices and personal mobile technology has turned hospital networks into important components in patient treatment.Practicing ...
Mytrus, a provider of clinical technology and services, has appointed Anthony Costello as the company's new chief executive officer (CEO). Costello replaces Steve Cummings, who is now the company's new chief scientific officer and will ...
Tags: clinical technology and services, oncology clinical data management